KIT and gastrointestinal stromal tumor: For example, KIT exon 11 mutated GISTs are very sensitive to imatinib, while wild-type GIST (defined as GIST without any mutations in the KIT and PDGFRA genes) is insensitive to imatinib, and has a poor prognosis23.